CLINICAL_TRIALS
trial_result
· 2014-01-27
Clinical Trial Update: Erlotinib in Treating Patients With Advanced Kidney Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating Erlotinib in advanced renal cell carcinoma has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-27